FDA inspection
McKesson Pharmaceutical Company: FDA inspection ending Dec 2, 2016
FDA inspection 995651 · No Action Indicated (NAI) · Rocky Hill, CT
Key facts
| Inspection ID | 995651 |
|---|---|
| Firm | McKesson Pharmaceutical Company |
| FEI number | 1215606 |
| Address | 280 Dividend Rd |
| City | Rocky Hill |
| State | CT |
| ZIP | 06067 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Dec 2, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Foodborne Biological Hazards |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data